BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lipitor
,
rs2230926
,
FGF21
,
Metabolism of xenobiotics
,
Influenza
,
Kidney
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
negative regulation of cytolysis
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Tongue
Oral mucosa
Pons
Thyroid gland
Coronary artery
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Congenital hypoplasia of kidney
Pyloric ulcer
Brucellosis
Infestation by Sarcoptes scabiei var canis
Syndrome of infant of diabetic mother
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
cidofovir
Neutrophil Extracellular Traps
interleukin-1beta (163-171)
AZD4547
CGP 60474
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Notch1
MAST4
TERC
PHF2
CHMP2A
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
Inflammatory arthritis response in TSG-6 knockout mice
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Pancreatic cancer YAPC.311 cells with CRISPR-targeted gene knockouts
L1000 CMAP - Umbilical vein endothelial HUVEC cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for negative regulation of cytolysis
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Impact of Denosumab in the Prevention of Bone Loss in Non-menopausal Women With Anorexia Nervosa
Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients Wi…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ